cerebrolysin April 12, 2017 cerebrolysin Trade Name Orphan Indication Frontotemporal dementia, including all subvariants USA Market Approval USA USA Designation Date 2016-04-05 00:00:00 Sponsor EVER Neuro Pharma GmbH;3 Oberburgau, 4866 Unterach;